In silico and in vitro analyses of a novel <scp>FoxO1</scp> agonist reducing Aβ levels via downregulation of <scp>BACE1</scp>Mingti Lv(Henan Medical University), Wei Zhang(Henan Medical University)CNS Neuroscience & TherapeuticsMarch 9, 202310.1111/cns.14140Cited by 5SaveCiteExport RISWatch citationsRelated PapersSalt-Inducing Assembly Polymorphism Strategy for Cytotoxicity Differentiation of Phenol-Soluble Modulin α3 Assemblies|Biomacromolecules|2022|6